Product Name
    Supplier
    Clonality
    Application
    Reactivity
    Price
    - 
        
            Recombinant Human TAR DNA-binding protein 43(TARDBP),partial (CSB-EP023129HU2)
CUSABIO
$224.00 - $1,812.00 - 
        
            Recombinant Human Somatostatin receptor type 5(SSTR5),partial (CSB-EP022728HU1)
CUSABIO
$306.00 - $2,466.00 - 
        
             - 
        
            Recombinant Human 3-oxo-5-alpha-steroid 4-dehydrogenase 2(SRD5A2),partial (CSB-EP022654HU1)
CUSABIO
$306.00 - $2,466.00 - 
        
             - 
        
            Recombinant Papio hamadryas Sperm acrosome membrane-associated protein 3(SPACA3),partial (CSB-EP022454ERJ)
CUSABIO
$388.00 - $2,466.00 - 
        
            Recombinant Human U1 small nuclear ribonucleoprotein A(SNRPA) (CSB-EP022327HUb1)
CUSABIO
$224.00 - $1,812.00 - 
        
             - 
        
             - 
        
            Recombinant Mouse Ribosomal protein S6 kinase alpha-4(Rps6ka4) (CSB-EP020467MO)
CUSABIO
$388.00 - $2,466.00 - 
        
            Recombinant Mouse Regulator of G-protein signaling 14(Rgs14) (CSB-EP019646MO)
CUSABIO
$388.00 - $2,466.00 - 
        
             - 
        
             - 
        
            Recombinant Mouse Prostaglandin E2 receptor EP4 subtype(Ptger4),partial (CSB-EP018973MO1)
CUSABIO
$554.00 - $2,632.00 - 
        
             - 
        
             - 
        
            Recombinant Mouse cGMP-dependent protein kinase 1(Prkg1) (CSB-EP018715MO)
CUSABIO
$388.00 - $2,466.00 - 
        
             - 
        
             - 
        
            Recombinant Human Group 10 secretory phospholipase A2(PLA2G10) (CSB-EP018085HU)
CUSABIO
$256.00 - $2,062.00 - 
        
             - 
        
             - 
        
             - 
        
            Recombinant Human Oxysterols receptor LXR-beta(NR1H2),partial (CSB-EP016045HU1a0)
CUSABIO
$306.00 - $2,466.00 - 
        
            Recombinant Human Oxysterols receptor LXR-beta(NR1H2),partial (CSB-EP016045HU1)
CUSABIO
$472.00 - $2,632.00 - 
        
             - 
        
             - 
        
             - 
        
             -